Synthesis and dopamine transporter binding affinities of 3α-benzyl-8-(diarylmethoxyethyl)-8-azabicyclo[3.2.1]octanes

Amy L. Bradley, Sari Izenwasser, Dean Wade, Cheryl Klein-Stevens, Naijue Zhu, Mark L. Trudell

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

A series of 3α-benzyl-8-(diarylmethoxyethyl)-8-azabicyclo[3.2.1]octanes was synthesized and the binding affinities of the compounds were determined at the dopamine transporter. The unsubstituted analogue 7b (Ki=98 nM) was the most potent compound of the series with binding affinity three-times greater than cocaine and only 5-fold less than GBR-12909. The structure-activity data for 7a-f suggests that these compounds may be binding at the dopamine transporter in a similar fashion to GBR 12909.

Original languageEnglish (US)
Pages (from-to)2387-2390
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume12
Issue number17
DOIs
StatePublished - Sep 2 2002

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Synthesis and dopamine transporter binding affinities of 3α-benzyl-8-(diarylmethoxyethyl)-8-azabicyclo[3.2.1]octanes'. Together they form a unique fingerprint.

  • Cite this